Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BE... by Carson, Peter, MD, Fiuzat, Mona, PharmD, O'Connor, Christopher, MD, Anand, Inder, MD, PhD, Plehn, Jonathan, MD, Lindenfeld, Jo Ann, MD, Silver, Marc, MD, White, Michel, MD, Miller, Alan, MD, Davis, Gordon, MS, MSPH, Robertson, Alastair D., PhD, Bristow, Michael, MD, PhD, Gottlieb, Stephen, MD

Get full text

Quality of Life and Prognosis in Heart Failure: Results of the Beta-Blocker Evaluation of Survival Trial (BEST) by Tate, Charles W., MD, Robertson, Alastair D., PhD, Zolty, Ronald, MD, Shakar, Simon F., MD, Lindenfeld, Joann, MD, Wolfel, Eugene E., MD, Bristow, Michael R., MD, PhD, Lowes, Brian D., MD

Get full text

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous ino... by Feldman, Arthur M., MD, PhD, Oren, Ron M., MD, Abraham, William T., MD, Boehmer, John P., MD, Carson, Peter E., MD, Eichhorn, Eric, MD, Gilbert, Edward M., MD, Kao, Andrew, MD, Leier, Carl V., MD, Lowes, Brian D., MD, Mathier, Michael A., MD, McGrew, Frank A., MD, Metra, Marco, MD, Zisman, Lawrence S., MD, Shakar, Simon F., MD, Krueger, Steven K., MD, Robertson, Alastair D., PhD, White, Bill G., PhD, Gerber, Michael J., MD, Wold, Gwyn E., MSPH, Bristow, Michael R., MD, PhD

Get full text

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial by Cohen, Jeffrey A, Prof, Coles, Alasdair J, PhD, Arnold, Douglas L, Prof, Confavreux, Christian, Prof, Fox, Edward J, MD, Hartung, Hans-Peter, Prof, Havrdova, Eva, Prof, Selmaj, Krzysztof W, Prof, Weiner, Howard L, Prof, Fisher, Elizabeth, PhD, Brinar, Vesna V, MD, Giovannoni, Gavin, Prof, Stojanovic, Miroslav, MD, Ertik, Bella I, MD, Lake, Stephen L, ScD, Margolin, David H, MD, Panzara, Michael A, MD, Compston, D Alastair S, Prof

Get full text

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study by Kalincik, Tomas, Dr, Brown, J William L, MD, Robertson, Neil, Prof, Willis, Mark, MD, Scolding, Neil, Prof, Rice, Claire M, PhD, Wilkins, Alastair, PhD, Pearson, Owen, MD, Ziemssen, Tjalf, MD, Hutchinson, Michael, Prof, McGuigan, Christopher, MD, Jokubaitis, Vilija, PhD, Spelman, Tim, PhD, Horakova, Dana, MD, Havrdova, Eva, Prof, Trojano, Maria, Prof, Izquierdo, Guillermo, MD, Lugaresi, Alessandra, MD, Prat, Alexandre, Prof, Girard, Marc, MD, Duquette, Pierre, Prof, Grammond, Pierre, MD, Alroughani, Raed, MD, Pucci, Eugenio, MD, Sola, Patrizia, MD, Hupperts, Raymond, Prof, Lechner-Scott, Jeannette, MD, Terzi, Murat, MD, Van Pesch, Vincent, Prof, Rozsa, Csilla, MD, Grand'Maison, François, Prof, Boz, Cavit, MD, Granella, Franco, MD, Slee, Mark, MD, Spitaleri, Daniele, MD, Olascoaga, Javier, MD, Bergamaschi, Roberto, MD, Verheul, Freek, MD, Vucic, Steve, MD, McCombe, Pamela, Prof, Hodgkinson, Suzanne, MD, Sanchez-Menoyo, Jose Luis, MD, Ampapa, Radek, MD, Simo, Magdolna, MD, Csepany, Tunde, MD, Ramo, Cristina, MD, Cristiano, Edgardo, MD, Barnett, Michael, MBBS, Butzkueven, Helmut, Prof, Coles, Alasdair, Prof

Get full text

Normal nonspecific bronchial reactivity excludes occupational asthma? by Walters, Gareth I., MD, Burge, P. Sherwood, MD, Moore, Vicky C., PhD, Robertson, Alastair S., MD

Get full text

Occupational asthma is a cause of adult-onset asthma with poor prognosis by Burge, P. Sherwood, MD, Moore, Vicky C., PhD, Robertson, Alastair S., FFOM

Get full text